Abstract:Background: Releasing growth factor through controlled release system is one of the study directions of bioactive factor application. Objective: To prepare transforming growth factor β1 (TGF-β 1) loaded chitosan microspheres with ionically cross-linking precipitant method, and to study the properties of controlled release of TGF-β 1 and biocompatibility in vitro. Design, time and setting: An observational trial was performed in the central labotatory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, Hubei, China) from October 2006 to September 2007. Materials: Chitosan, 90% deacetylation degree, was offered by Tsinghua University Chemical Engineering Department; TGF-β 1 was offered by Jingmei Biotech Co., Ltd.; Rats were offered by the Experimental Animal Center of Tongji Medical College, Huazhong University of Science and Technology. Methods: Chitosan microspheres were prepared with ionically cross-linking precipitant method, and TGF-β 1 was then packaged in the microspheres. After passage culture, myofibroblasts in descending thoracic aorta of rats at the adjusted concentration of 1× 10 8/L were added with chitosam microsphere leaching liquor (4, 2, 1 g/L), while the medium without leaching liquor was taken as controls. Main outcome measures: The features such as the size distribution, drug content, drug encapsulating and in vitro release were studied with scanning electron microscope, laser grainsize analyzer and ELISA method. MTT test was performed to observe cell proliferation and evaluate the biocompatibility in vitro. Results: The microspheres were spherical and smooth. The mean diameters of the spheres were 272 nm, and the high encapsulation efficiency was obtained, about 80.6%. The sudden release of TGF-β 1 was observed in the initial period in test of release in vitro, and then TGF-β 1 could be constantly released from the chitosan microspheres (27% in 24 hours and up to 41% in 7 days). MTT showed that the chitosan microspheres did not damage the cell growth in vitro, indicating good compatibility. Conclusion: The method to prepare chitosan microspherea with ionically cross-linking precipitant is convenient and feasible, and TGF-β 1 possesses good delayed release and compatibility.

Preparation of Chitosan Scaffolds Controlling-released bFGF and its Effect on Cell Culture

Preparation and Release Behavior of Chitosan Scaffolds Encapsulating Proteins Loaded in PLGA Microspheres

[Preparation of Alginate-Chitosan-poly (Lactic-Co-glycolic Acid) Composite Microsphere and Its Regulation of Protein Release].

From Common Biomass Materials to High-Performance Tissue Engineering Scaffold: Biomimetic Preparation, Properties Characterization, in Vitro and in Vivo Evaluations

In Vivo Validation of Biological Responses of Bfgf Released from Microspheres Formulated by Blending Poly-Lactide-co-Glycolide and Poly(ethylene Glycol)-Grafted-chitosan in Hamster Cheek Pouch Microcirculatory Models

PLA tissue-engineered scaffolds loaded with sustained-release active substance chitosan nanoparticles: Modeling BSA-bFGF as the active substance

Preparation of Hybrid Scaffold of PLGA Sponge/Fibrin Gel/BMSCs/DNA Complexes with Enhanced Property for BMSCs Differentiation

Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres

Fabrication, Characterization and in Vitro Drug Release Behavior of Electrospun PLGA/chitosan Nanofibrous Scaffold

In Vitro Degradation and Release Behavior of Porous Poly(lactic Acid) Scaffolds Containing Chitosan Microspheres As a Carrier for BMP-2-derived Synthetic Peptide

Experimental Study on Cultivation and Purification of Bone Marrow-Derived Mesenchymal Stem Cells and Its Co-Culture with Chitosan Porous Scaffolds in Vitro

Preparation and in vitro compatibility of transforming growth factor beta 1 loaded chitosan microspheres

Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2.

Preparation and characterization of poly(L-lactic acid)-chitosan hybrid scaffolds with drug release capability

Porous Nano-Ha/collagen/plla Scaffold Containing Chitosan Microspheres for Controlled Delivery of Synthetic Peptide Derived from BMP-2.

Surface Modification of Biodegradable Plga Scaffold with Chitosan for Cell Culture

Effects of surface functionalization of PLGA membranes for guided bone regeneration on proliferation and behavior of osteoblasts.

Controlled release of FGF-2 and BMP-2 in tissue engineered periosteum promotes bone repair in rats

PREPARATION OF SULFATED CHITOSAN/POLYLYSINE/TRANSFORM GROWTH FACTOR-β1 NANOPARTICLES AND THEIR ABILITY TO INDUCE CHONDROGENESIS DIFFERENTIATION OF BMSCs

Reparation of Sulfonated Chitosan and Its Ability to Protect Bfgf Activites

Modification of Polycaprolactone Microspheres-Aggregated Scaffolds with Galactosylated Chitosan for Modulating the Differentiation of Bone Mesenchymal Stem Cells